Sensus Healthcare, Inc (SRTS) is a publicly traded Healthcare sector company. As of May 21, 2026, SRTS trades at $3.07 with a market cap of $57.12M and a P/E ratio of -6.94. SRTS moved -2.84% today. Year to date, SRTS is -25.39%; over the trailing twelve months it is -30.83%. Its 52-week range spans $2.82 to $9.33. Analyst consensus is strong buy with an average price target of $5.67. Rallies surfaces SRTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes SRTS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $3.07 |
| Market Cap | $57.12M |
| P/E Ratio | -6.94 |
| EPS | $-0.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.33 |
| 52-Week Low | $2.82 |
| Volume | 128 |
| Avg Volume | 0 |
| Revenue (TTM) | $22.53M |
| Net Income | $-7.77M |
| Gross Margin | 37.74% |
3 analysts cover SRTS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.67.